Galena Biopharma (GALE) Posts Surprise Q4 Profit of 4c/Share

Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of $0.04, $0.19 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• RenovoRx regains Nasdaq minimum bid price compliance